What is Motus GI Holdings, Inc. (MOTS) stock price today?

Motus GI Holdings, Inc. (MOTS) is currently trading at $0.00.

What is MOTS P/E ratio?

Motus GI Holdings, Inc.'s P/E ratio is 0.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is MOTS return on equity (ROE)?

Motus GI Holdings, Inc.'s return on equity (ROE) is -433.33%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Motus GI Holdings, Inc.'s market cap?

Motus GI Holdings, Inc. has a market capitalization of $639.

OTC · Medical - Devices

Motus GI Holdings, Inc. (MOTS) Stock

$0.00 OTC: MOTS Healthcare

Motus GI Holdings, Inc. operates as a medical technology company in the United States.

Valuation

Metric	Value
Price	$0.00
Market Cap	$639
P/E Ratio	0.00
P/B Ratio	0.00
P/S Ratio	0.00
EPS (TTM)	$-2.96
52-Week High	$0.10
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-433.33%
ROA	-62.02%
ROCE	-301.21%
Gross Margin	-24.46%
Operating Margin	-3165.62%
Net Margin	0.00%
Debt/Equity	0.79
Current Ratio	1.74

Annual Financials (USD)

Metric	2019	2020	2021	2022	2023
Revenue	$0	$0	$0	$1.0M	$0
Operating Profit	$-23.0M	$-19.0M	$-18.0M	$-18.0M	$-12.0M
Net Profit	$-23.0M	$-19.0M	$-19.0M	$-19.0M	$-13.0M
EPS	$-269.69	$-179.86	$-161.07	$-86.15	$-15.89
Op Margin	-21902.8%	-19435.7%	-4584.1%	-3015.4%	-3732.6%

Balance Sheet (USD)

Metric	2019	2020	2021	2022	2023
Total Assets	$32.0M	$24.0M	$26.0M	$18.0M	$7.0M
Total Liabilities	$14.0M	$13.0M	$16.0M	$15.0M	$5.0M
Cash	$21.0M	$21.0M	$23.0M	$14.0M	$5.0M
Borrowings	$9.0M	$9.0M	$12.0M	$11.0M	$2.0M

Cash Flow (USD)

Metric	2019	2020	2021	2022	2023
Operating Cash Flow	$-20.0M	$-17.0M	$-14.0M	$-17.0M	$-11.0M
Investing Cash Flow	$-6.0M	$8.0M	$-1.0M	$0	$0
Financing Cash Flow	$0	$-1.0M	$11.0M	$0	$-1.0M
Net Cash Flow	$2.0M	$0	$2.0M	$-9.0M	$-9.0M
Free Cash Flow	$-20.0M	$-17.0M	$-15.0M	$-18.0M	$-11.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	0.22
FCF Yield	-1768075.12%
Quick Ratio	1.69
Interest Coverage	-15.65
Return 1Y	0.00%
Return 3Y	-100.00%
Return 5Y	—

Ownership

Insiders Held0.00%

Institutions Held0.00%

Institutions Float Held0.00%

Institutional Holder	Shares	Report Date
Motiv8 Investments LLC	1	2025-12-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ATRXAdhera Therapeutics Inc	$0.00	—	0.00	$722	0.00%
BIIOBionovate Technologies Corp	$0.00	—	-0.04	$775	0.00%
CNNXFCannAmerica Brands Corp.	$0.00	—	0.00	$704	0.00%
GBIMGlobeImmune, Inc.	$0.00	—	0.00	—	0.00%
HRALHear AtLast Holdings, Inc.	$0.00	—	0.00	$297	0.00%

About Motus GI Holdings, Inc.

Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.

Motus GI Holdings, Inc. (MOTS) stock trades at $0.00 with a market capitalization of $639. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.10, and currently trades 100.0% below its 52-week high.

On profitability, Motus GI Holdings, Inc. generates a return on equity (ROE) of -433.33%, return on capital employed of -301.21%, an operating margin of -3165.62%, a net profit margin of 0.00%.

Official website: www.motusgi.com

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides